These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 30474946)

  • 1. [Radionuclide therapy for bone metastases by drugs based on Re-188].
    Liepe K; Krylov VV; Kochetova TY
    Vopr Onkol; 2016; 62(4):401-9. PubMed ID: 30474946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of rhenium-188, rhenium-186-HEDP and strontium-89 in palliation of painful bone metastases].
    Liepe K; Franke WG; Kropp J; Koch R; Runge R; Hliscs R
    Nuklearmedizin; 2000 Sep; 39(6):146-51. PubMed ID: 11057405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Palliative analgesic effect of Re-186 HEDP in various cancer patients with bone metastases.
    Küçük NO; Ibiş E; Aras G; Baltaci S; Ozalp G; Bedük Y; Canakci N; Soylu A
    Ann Nucl Med; 2000 Aug; 14(4):239-45. PubMed ID: 11023023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of painful bone metastases in prostate and breast cancer patients with the therapeutic radiopharmaceutical rhenium-188-HEDP. Clinical benefit in a real-world study.
    Lange R; Overbeek F; de Klerk JM; Pasker-de Jong PC; van den Berk AM; Ter Heine R; Rodenburg CJ; Kooistra A; Hendrikse NH; Bloemendal HJ
    Nuklearmedizin; 2016 Sep; 55(5):188-95. PubMed ID: 27443809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 186Re-HEDP for metastatic bone pain in breast cancer patients.
    Lam MG; de Klerk JM; van Rijk PP
    Eur J Nucl Med Mol Imaging; 2004 Jun; 31 Suppl 1():S162-70. PubMed ID: 15118846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rhenium-186 HEDP: palliative radionuclide therapy of painful bone metastases. Preliminary results.
    Schoeneich G; Palmedo H; Dierke-Dzierzon C; Müller SC; Biersack HJ
    Scand J Urol Nephrol; 1997 Oct; 31(5):445-8. PubMed ID: 9406304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significant reduction of the mass of bone metastasis 1 year after rhenium-186 HEDP pain palliation therapy.
    Liepe K; Kropp J; Hliscs R; Franke WG
    Clin Nucl Med; 2000 Nov; 25(11):901-4. PubMed ID: 11079588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical experience with rhenium-188 HEDP therapy for metastatic bone pain].
    Róka R; Séra T; Pajor L; Thurzó L; Láng J; Csernay L; Pávics L
    Orv Hetil; 2000 May; 141(19):1019-23. PubMed ID: 10846424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metastatic bone pain palliation with 89-Sr and 186-Re-HEDP in breast cancer patients.
    Sciuto R; Festa A; Pasqualoni R; Semprebene A; Rea S; Bergomi S; Maini CL
    Breast Cancer Res Treat; 2001 Mar; 66(2):101-9. PubMed ID: 11437096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pain therapy in multiple bone metastases in breast carcinoma with rhenium 186 HEDP].
    Hauswirth AE; Palmedo H; Dierke-Dzierzon C; Biersack HJ; Krebs D
    Zentralbl Gynakol; 1998; 120(2):83-6. PubMed ID: 9531713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remission of bone metastases after combined chemotherapy and radionuclide therapy with Re-186 HEDP.
    Palmedo H; Grünwald F; Wagner U; Köhler S; Krebs D; Biersack HJ
    Clin Nucl Med; 1998 Aug; 23(8):501-4. PubMed ID: 9712380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pain therapy with rhenium-186 HEDP in multiple bone metastases].
    Palmedo H; Bender H; Schomburg A; Grünwald F; Schöneich G; Zamorra P; Reichmann K; Dierke-Dzierzon C; Mallmann P; Biersack HJ
    Nuklearmedizin; 1996 Apr; 35(2):63-7. PubMed ID: 8721578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic efficiency of rhenium-188-HEDP in human prostate cancer skeletal metastases.
    Liepe K; Kropp J; Runge R; Kotzerke J
    Br J Cancer; 2003 Aug; 89(4):625-9. PubMed ID: 12915868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic radionuclide therapy in pain palliation.
    Liepe K; Runge R; Kotzerke J
    Am J Hosp Palliat Care; 2005; 22(6):457-64. PubMed ID: 16323716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiopharmaceuticals for Palliation of Bone Pain in Patients with Castration-resistant Prostate Cancer Metastatic to Bone: A Systematic Review.
    Jong JM; Oprea-Lager DE; Hooft L; de Klerk JM; Bloemendal HJ; Verheul HM; Hoekstra OS; van den Eertwegh AJ
    Eur Urol; 2016 Sep; 70(3):416-26. PubMed ID: 26391636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Palliation of bone pain in metastatic prostate carcinoma. Value of radionuclide therapy with rhenium 186 HEDP].
    Klutmann S; Bohuslavizki KH
    MMW Fortschr Med; 1999 Nov; 141(44):38-9. PubMed ID: 10912142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiometabolic treatment of bone-metastasizing cancer: from 186rhenium to 223radium.
    Rubini G; Nicoletti A; Rubini D; Asabella AN
    Cancer Biother Radiopharm; 2014 Feb; 29(1):1-11. PubMed ID: 24180669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Availability of rhenium-188 from the alumina-based tungsten-188/rhenium-188 generator for preparation of rhenium-188-labeled radiopharmaceuticals for cancer treatment.
    Knapp FF; Beets AL; Guhlke S; Zamora PO; Bender H; Palmedo H; Biersack HJ
    Anticancer Res; 1997; 17(3B):1783-95. PubMed ID: 9179235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Labelling of Re-ABP with 188Re for bone pain palliation.
    Arteaga de Murphy C; Ferro-Flores G; Pedraza-López M; Meléndez-Alafort L; Croft BY; Ramírez FM; Padilla J
    Appl Radiat Isot; 2001 Mar; 54(3):435-42. PubMed ID: 11214878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pain palliation with rhenium-186 HEDP in breast cancer patients with disseminated bone metastases.
    Palmedo H; Bender H; Dierke-Dzierzon C; Carl UM; Risse J; Krebs D; Biersack HJ
    Clin Nucl Med; 1999 Sep; 24(9):643-8. PubMed ID: 10478737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.